These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25812850)

  • 61. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
    Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
    Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid.
    Laakso MP; Jukarainen NM; Vepsäläinen J
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1286-90. PubMed ID: 26203158
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
    Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer's Disease and Dementia with Lewy Bodies.
    Longobardi A; Nicsanu R; Bellini S; Squitti R; Catania M; Tiraboschi P; Saraceno C; Ferrari C; Zanardini R; Binetti G; Di Fede G; Benussi L; Ghidoni R
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.
    Nielsen HM; Minthon L; Londos E; Blennow K; Miranda E; Perez J; Crowther DC; Lomas DA; Janciauskiene SM
    Neurology; 2007 Oct; 69(16):1569-79. PubMed ID: 17761554
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.
    Vinceti M; Chiari A; Eichmüller M; Rothman KJ; Filippini T; Malagoli C; Weuve J; Tondelli M; Zamboni G; Nichelli PF; Michalke B
    Alzheimers Res Ther; 2017 Dec; 9(1):100. PubMed ID: 29258624
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
    Yilmaz A; Fuchs D; Price RW; Spudich S; Blennow K; Zetterberg H; Gisslén M
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):76-81. PubMed ID: 30649659
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer's disease.
    Casoli T; Paolini S; Fabbietti P; Fattoretti P; Paciaroni L; Fabi K; Gobbi B; Galeazzi R; Rossi R; Lattanzio F; Pelliccioni G
    J Int Med Res; 2019 Oct; 47(10):4968-4980. PubMed ID: 31524025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.
    Oeckl P; Halbgebauer S; Anderl-Straub S; Steinacker P; Huss AM; Neugebauer H; von Arnim CAF; Diehl-Schmid J; Grimmer T; Kornhuber J; Lewczuk P; Danek A; ; Ludolph AC; Otto M
    J Alzheimers Dis; 2019; 67(2):481-488. PubMed ID: 30594925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.
    Lang V; Zille M; Infante-Duarte C; Jarius S; Jahn H; Paul F; Ruprecht K; Pina AL
    J Neurol Sci; 2017 Apr; 375():123-128. PubMed ID: 28320113
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
    Zhao Y; Xin Y; Meng S; He Z; Hu W
    Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.
    Green AJ; Harvey RJ; Thompson EJ; Rossor MN
    Neurosci Lett; 1997 Oct; 235(1-2):5-8. PubMed ID: 9389582
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
    Nielsen HM; Palmqvist S; Minthon L; Londos E; Wennström M
    Curr Alzheimer Res; 2012 Mar; 9(3):257-66. PubMed ID: 22191565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.
    Musaeus CS; Gleerup HS; Høgh P; Waldemar G; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2020; 75(2):429-436. PubMed ID: 32280104
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CSF biomarkers in neurodegenerative and vascular dementias.
    Llorens F; Schmitz M; Ferrer I; Zerr I
    Prog Neurobiol; 2016; 138-140():36-53. PubMed ID: 27016008
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
    Janelidze S; Hertze J; Nägga K; Nilsson K; Nilsson C; ; Wennström M; van Westen D; Blennow K; Zetterberg H; Hansson O
    Neurobiol Aging; 2017 Mar; 51():104-112. PubMed ID: 28061383
    [TBL] [Abstract][Full Text] [Related]  

  • 77. State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia-A Short Review and Diagnostic Algorithm.
    Solje E; Benussi A; Buratti E; Remes AM; Haapasalo A; Borroni B
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925655
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
    Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
    Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Group of Long Non-coding RNAs in Blood Acts as a Specific Biomarker of Alzheimer's Disease.
    Ren Z; Chu C; Pang Y; Cai H; Jia L
    Mol Neurobiol; 2023 Feb; 60(2):566-575. PubMed ID: 36327022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.
    Nakayama Y; Morimoto S; Yoneda M; Kuzuhara S; Kokubo Y
    J Neurodegener Dis; 2013; 2013():679089. PubMed ID: 26316995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.